Chronic Lymphocytic Leukemia Patients Need Both Molecular And Clinical Risk Assessments

Dr. Deborah M. Stephens from the Huntsman Cancer Institute recently presented at the 39th Annual Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow (CFS). The presentation surrounded how critical identifying…

Continue Reading Chronic Lymphocytic Leukemia Patients Need Both Molecular And Clinical Risk Assessments